Drug Profile
Research programme: camptothecin analogues - Threshold
Alternative Names: TH-1320Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Threshold Pharmaceuticals
- Class
- Mechanism of Action DNA topoisomerase I inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA (PO)
- 21 Apr 2010 Preclinical trials in Cancer in USA (PO)
- 21 Apr 2010 Pharmacodynamics and adverse events data from preclinical trials in Cancer presented at the 101st Annual Meeting of the American Association for Cancer Research (AACR-2010)